Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InfuSystem is a leading U.S. and Canadian provider of ambulatory and large-volume infusion pumps and related services for hospitals, oncology practices, surgery centers, home health agencies, and patients. The company operates a fleet of over 100,000 devices with integrated therapy support—including clinical staff assistance—and has exclusive distribution agreements for certain medical devices such as the Chemo Mouthpiece for oral mucositis relief in chemotherapy patients. It is publicly traded on the NYSE American under "INFU" and reported strong revenue growth in its core segments as of Q1 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InfuSystem.